DOI: 10.1097/MOL.0000000000000029
,
,
PMID: 24231280
Issn Print: 0957-9672
Publication Date: 2013/12/01
Choice of medical therapy to lower triglycerides in those at risk of pancreatitis
David Preiss; Naveed Sattar
Excerpt
The relationship between triglyceride levels and cardiovascular risk remains complex with large, high-quality epidemiological studies indicating that triglyceride levels do not predict risk beyond other lipids and usual classical risk factors [1], whereas studies of genetic polymorphisms suggest that triglycerides-related pathways may indeed have a causal factor [2]. Statin therapy remains first-line therapy for cardiovascular risk reduction regardless of triglyceride levels [3].